
Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript
Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
| Revenue (TTM) | $800.82M |
| Gross Profit (TTM) | $687.05M |
| EBITDA | $152.38M |
| Operating Margin | 22.50% |
| Return on Equity | 47.60% |
| Return on Assets | 11.40% |
| Revenue/Share (TTM) | $10.06 |
| Book Value | $3.70 |
| Price-to-Book | 31.26 |
| Price-to-Sales (TTM) | 11.66 |
| EV/Revenue | 11.36 |
| EV/EBITDA | 58.41 |
| Quarterly Earnings Growth (YoY) | -68.40% |
| Quarterly Revenue Growth (YoY) | 52.40% |
| Shares Outstanding | $62.47M |
| Float | $50.73M |
| % Insiders | 4.74% |
| % Institutions | 99.49% |
Volatility is currently contracting

Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health NYSE: HNGE reported third-quarter revenue growth of 52% year over year and raised its full-year outlook, as the digital musculoskeletal care company cited higher member engagement, client additions and improved operating leverage.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. “Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale," said Daniel Perez, Co-Founder and CEO, Hinge Health. "This focus on the triple aim, via a technology platform that scales and automates care delivery, is also.

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relation.

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?

Baron Small Cap Fund (the Fund) was up 12.57% (Institutional Shares) in the second quarter, trailing the Russell 2000 Growth Index (the Index) by 13.14%, as the Index was up 25.71%. Shares increased during the quarter as Vertiv reported strong Q1 financial results (adjusted earnings per share increased 83% year-over-year) and increased fiscal year guidance fueled by organic sales growth of around 30%. Planet Fitness, Inc. , the leading high-value, low-cost gym operator, detracted from performance in the second quarter after the company lowered full-year guidance following weaker-than-expected member additions in the first quarter.

Bond yields have the entire stock market on edge. The last thing most investors are thinking about is short squeezes, which means maybe they should be something contrarian trades have on their radar.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HNGE and any ticker you trade — then tracks every position and per-strategy win rate.